News & Events RSS Feed

10 April 2014

Physiomics to present the second validation of its Virtual Tumour Clinical platform at the CASyM Systems Biology Academia/Industry workshop in Lyon on April 10th

Physiomics is pleased to announce that it is presenting at the CASyM Academic / Industry interaction workshop taking place in Lyon (France) on April 10th 2014. Dr Hitesh Mistry will present on validation of the Virtual Tumour Clinical platform in melanoma to an audience that will comprise senior academics and large pharmaceutical company scientists. Read […]

3 April 2014

Physiomics to present first validation of its Virtual Tumour Clinical platform at AACR

Physiomics is pleased to announce that it is participating in the AACR Annual Meeting 2014, taking place at the San Diego Convention Center, San Diego, CA on 5-9 April 2014. Dr Eric Fernandez will present on the first validation of the Virtual Tumour Clinical platform. Read more.

14 February 2014

Interim Results Statement for the six month period ended 31 December 2013

The Board of Physiomics today announces its interim financial results for the six months ended 31 December 2013. Read more.

16 January 2014

Physiomics to collaborate with the University of Dundee to “optimize drug design and testing” with grant support from the Northern Research Partnership

Physiomics plc is pleased to announce that it has signed a collaboration agreement with the University of Dundee. Physiomics part of the collaboration will be fully funded by the Northern Research Partnership (“NRP”) in the form of an “Early Career Researcher Engagement and Exchanges with Business & Industry” agreement. Read more.

4 December 2013

New Agreement to advance inhibitor of novel target with global pharma company

Physiomics is pleased to announce that it has signed a substantial new contract with a major global pharmaceutical company. The programme of studies will begin immediately and take an estimated 9 months to reach a conclusion. Physiomics will determine the optimal dosing regimen of a new compound currently under development by this client. Read more.

28 November 2013

Physiomics launches new DrugCARD® database for oncology researchers and clinicians

Physiomics is pleased to announce that it has now launched its Drug Combinations and Regimens database. DrugCARD® collates curated publicly available pre-clinical and clinical drug regimen data into one easily searchable tool. It also contains further clinical data and analysis which is only available through the collaboration with Pharmacometrics. Read more.

28 November 2013

Physiomics is recruiting: Biosimulation Scientist

We have an opportunity for a Biosimulation Scientist to join our technical team to work on projects related to drug development. Find more details at our careers page.

Page 3 of 1612345...10...Last